FINWIRES · TerminalLIVE
FINWIRES

Ligand Pharmaceuticals Closes $739 Million XOMA Royalty Purchase

By

Ligand Pharmaceuticals (LGND) has completed its acquisition of XOMA Royalty (XOMA) for an equity value of about $739 million, the company said Tuesday.

XOMA Royalty shareholders received $39 in cash per share and one non-transferable contingent value right tied to a portion of proceeds from certain pending litigation, the company said.

Ligand said the acquisition adds seven commercial products, 14 late-stage development programs and more than 100 development and commercial-stage assets.

The company said the transaction is expected to add about $0.50 per share and $1.50 per share to its projected adjusted earnings per share in 2026 and 2027, respectively.

Ligand said it expects to provide an updated five-year outlook at its Investor Day on Dec. 8.

Following the closing, XOMA Royalty's common stock stopped trading on the Nasdaq Global Market, the company said.

Price: $307.59, Change: $-1.66, Percent Change: -0.54%

Related Articles

Wire

Rithm Property Trust Launches Public Offering of Common Shares

Rithm Property Trust (RPT) said late Monday it launched a public offering of common shares.The company will grant underwriters a 30-day overallotment option to buy an additional 15% of the shares offered, according to a statement.An affiliate Rithm Capital has shown interest in buying common shares in a concurrent private placement, according to the company.Net proceeds will be used to acquire a portfolio of multifamily residential transition loans from affiliates of Rithm Capital, and for general corporate purposes, the company said.

$RPT
Wire

Penguin Solutions Plans $650 Million Convertible Notes Offering

Penguin Solutions (PENG) intends to offer $650 million in convertible senior notes due 2031 to institutional buyers, with initial purchasers expected to receive an option to buy up to an additional $100 million in notes, the company said Monday in a statement.Penguin expects to use the net proceeds to fund capped call transactions, pay the cash portion of exchanges for its existing 2029 and 2030 convertible notes, repay $100 million outstanding under its credit agreement, and for general corporate purposes.The company's shares fell 4.4% in after-hours trading.

$PENG
Wire

Erasca Plans $500 Million Underwritten Offering of Common Stock

Erasca (ERAS) plans to sell $500 million in common stock in an underwritten public offering.Underwriters are expected to receive a 30-day option to buy up to an additional $75 million in shares, the company said Monday in a statement.Erasca expects to use the net proceeds to finance research and development, and for working capital and general corporate purposes.The company's shares fell 2.2% in after-hours trading.

$ERAS